UK Study Integrates PrecivityAD2 Blood Test for Alzheimer’s in Primary Care
Researchers in the United Kingdom are integrating the PrecivityAD2 blood test from C2N Diagnostics into the Alzheimer’s disease…
Ultrasensitive Blood Test Detects Sjögren’s Disease Years Early, Study Finds
An ultrasensitive blood test could detect Sjögren’s disease more than a decade before a clinical diagnosis, according to…
Blood Test Predicts Chemotherapy Benefit in Colorectal Cancer, Study Finds
A blood test may help identify which patients with colorectal cancer that has spread to the liver are…
Oncology Insights with Dr. Petros Grivas – Episode 16
Since its earliest days, Fred Hutch Cancer Center’s story has been closely tied to bone marrow transplantation. E.…
Blood Test Detects HPV-Related Head and Neck Cancer Recurrence Risk
Investigators from Mass General Brigham Cancer Institute have developed an ultrasensitive blood test that identifies patients with human…
New Blood Test Method Improves HDL Function Analysis in Heart Disease
Researchers at the Institute of Science Tokyo developed a blood-based assessment to measure how effectively high-density lipoprotein (HDL)…
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards
Two researchers at Fred Hutch Cancer Center recently received Young Investigator Awards from the Prostate Cancer Foundation for…
Tip Sheet: Improving outcomes for stem cell transplants, exploring the link between solar jetlag and liver cancer — and expanding cancer treatment targets
Is there a way to boost immunotherapy response?
Molecular biologist Kevin Barry, PhD, received a $270,000, two-year grant…
Home HPV Self-Sampling Kits Show Promise for Closing Cervical Screening Gap in Disabled Women
A new study from the University of Sheffield suggests that at-home human papillomavirus (HPV) self-sampling kits could help…
Novel antibody blocks Epstein-Barr virus, curing follicular lymphoma — and a plan to reduce cancer in Washington state
SEATTLE – March 4, 2026 – Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite…
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite…